This week’s Neuron has an extremely well written article on advice for students entering Ph.D. programs (http://www.cell.com/neuron/abstract/S0896-6273%2813%2901191-4). This follows on from Ben Barre’s article in Cell. It’s rare that I agree with everything said in an article but every point here is spot on! Indeed, I think PIs can take some of this advice to heart to…experienced or not.
All posts by author
Are you talented, creative and highly motivated? Shepherd Laboratory is currently looking for new talent. If you are passionate about scientific research and innovation, motivated, ambitious and driven; we want you to be part of our team.
We are seeking talented and enthusiastic postdocs to join the Shepherd lab. The lab utilizes coordinated biochemical, cell biological, electrophysiological and imaging studies in vitro and in vivo, including state of the art techniques such as in vivo two-photon microscopy and chronic electrophysiological recordings in live animals (Nat Neurosci. 2010 Apr;13(4):450-7).
Projects will range from basic mechanisms of memory storage (Neuron. 2006 Nov 9;52(3):445-59 and Nat Neurosci. 2011 Mar;14(3):279-84) to understanding neurological diseases, including Alzheimer’s disease (Cell. 2011 Oct 28;147(3):615-28.) and neurodevelopmental disorders such Angelman and Fragile X syndrome (Neuron. 2008 Jul 10;59(1):70-83). We are particularly interested in people with molecular biology/biochemistry/cell biology experience or electrophysiology/imaging experience.
There is a growing and vibrant neuroscience community at the University of Utah, with an excellent quality of life. Nestled in the Wasatch mountains, Salt Lake City offers both cultural (Sundance Film festival) and outdoor recreation (over 5 world class ski resorts with 30 minutes) activities.
The lab is well funded through a generous startup package and a K99/R00 from the NINDS.Apply Today!
The Shepherd lab has been awarded a 2 year research grant from the Angelman Syndrome Foundation to test the causal role of Arc in Angelman Syndrome. Only six labs worldwide were funded this year.
Due to the generosity from its supporters, the ASF has approved funding for more than $1.25 million in research grants in this grant cycle. After evaluating this year’s proposals, the ASF’s Scientific Advisory Committee and Board of Directors decided that each of the following studies are essential to advancing Angelman syndrome research. These initiatives are quintessential to the success of all future Angelman syndrome preclinical and clinical trials… learn more »